[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone

C134H130F10N28O6 — CID 158763937

IUPAC[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone
SMILESCCCc1cn(CC23CC(C(=O)N4N=CCC4c4cc(F)cc(F)c4)(C2)C3)nn1.CCc1cn(CC23CC(C(=O)N4N=CCC4c4cc(F)cc(F)c4)(C2)C3)nn1.Cc1c2ccccc2nn1CC12CC(C(=O)N3N=CCC3c3cc(F)cc(F)c3)(C1)C2.Cc1cnc(C2CC=NN2C(=O)C23CC(Cn4ncc5ccccc54)(C2)C3)cn1.Cc1nn(CC23CC(C(=O)N4N=CCC4c4cc(F)cc(F)c4)(C2)C3)c2ccccc12.O=C(N1N=CCC1c1cc(F)cc(F)c1)C12CC(Cn3ncc4ccccc43)(C1)C2
InChIInChI=1S/2C24H22F2N4O.C23H20F2N4O.C22H22N6O.C21H23F2N5O.C20H21F2N5O/c1-15-19-4-2-3-5-21(19)29(28-15)14-23-11-24(12-23,13-23)22(31)30-20(6-7-27-30)16-8-17(25)10-18(26)9-16;1-15-19-4-2-3-5-20(19)28-29(15)14-23-11-24(12-23,13-23)22(31)30-21(6-7-27-30)16-8-17(25)10-18(26)9-16;24-17-7-16(8-18(25)9-17)20-5-6-26-29(20)21(30)23-11-22(12-23,13-23)14-28-19-4-2-1-3-15(19)10-27-28;1-15-8-24-17(10-23-15)19-6-7-25-28(19)20(29)22-11-21(12-22,13-22)14-27-18-5-3-2-4-16(18)9-26-27;1-2-3-17-9-27(26-25-17)13-20-10-21(11-20,12-20)19(29)28-18(4-5-24-28)14-6-15(22)8-16(23)7-14;1-2-16-8-26(25-24-16)12-19-9-20(10-19,11-19)18(28)27-17(3-4-23-27)13-5-14(21)7-15(22)6-13/h2-5,7-10,20H,6,11-14H2,1H3;2-5,7-10,21H,6,11-14H2,1H3;1-4,6-10,20H,5,11-14H2;2-5,7-10,19H,6,11-14H2,1H3;5-9,18H,2-4,10-13H2,1H3;4-8,17H,2-3,9-12H2,1H3
InChIKeyIPAFKYUFQPLGAJ-UHFFFAOYSA-N
MW2418.68 g/mol
LogP24.10
Rot. Bonds27

About [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone

[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone (PubChem CID 158763937) has the molecular formula C134H130F10N28O6 and a molecular weight of 2418.68 g/mol. Its IUPAC name is [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone.

Molecular Properties

Compound Name[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone
PubChem CID158763937
Molecular FormulaC134H130F10N28O6
Molecular Weight2418.68 g/mol
Exact Mass2417.06
IUPAC Name[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone
SMILESCCCc1cn(CC23CC(C(=O)N4N=CCC4c4cc(F)cc(F)c4)(C2)C3)nn1.CCc1cn(CC23CC(C(=O)N4N=CCC4c4cc(F)cc(F)c4)(C2)C3)nn1.Cc1c2ccccc2nn1CC12CC(C(=O)N3N=CCC3c3cc(F)cc(F)c3)(C1)C2.Cc1cnc(C2CC=NN2C(=O)C23CC(Cn4ncc5ccccc54)(C2)C3)cn1.Cc1nn(CC23CC(C(=O)N4N=CCC4c4cc(F)cc(F)c4)(C2)C3)c2ccccc12.O=C(N1N=CCC1c1cc(F)cc(F)c1)C12CC(Cn3ncc4ccccc43)(C1)C2
InChIInChI=1S/2C24H22F2N4O.C23H20F2N4O.C22H22N6O.C21H23F2N5O.C20H21F2N5O/c1-15-19-4-2-3-5-21(19)29(28-15)14-23-11-24(12-23,13-23)22(31)30-20(6-7-27-30)16-8-17(25)10-18(26)9-16;1-15-19-4-2-3-5-20(19)28-29(15)14-23-11-24(12-23,13-23)22(31)30-21(6-7-27-30)16-8-17(25)10-18(26)9-16;24-17-7-16(8-18(25)9-17)20-5-6-26-29(20)21(30)23-11-22(12-23,13-23)14-28-19-4-2-1-3-15(19)10-27-28;1-15-8-24-17(10-23-15)19-6-7-25-28(19)20(29)22-11-21(12-22,13-22)14-27-18-5-3-2-4-16(18)9-26-27;1-2-3-17-9-27(26-25-17)13-20-10-21(11-20,12-20)19(29)28-18(4-5-24-28)14-6-15(22)8-16(23)7-14;1-2-16-8-26(25-24-16)12-19-9-20(10-19,11-19)18(28)27-17(3-4-23-27)13-5-14(21)7-15(22)6-13/h2-5,7-10,20H,6,11-14H2,1H3;2-5,7-10,21H,6,11-14H2,1H3;1-4,6-10,20H,5,11-14H2;2-5,7-10,19H,6,11-14H2,1H3;5-9,18H,2-4,10-13H2,1H3;4-8,17H,2-3,9-12H2,1H3
InChIKeyIPAFKYUFQPLGAJ-UHFFFAOYSA-N
XLogP24.10
TPSA354.50 Ų
H-Bond Donors
H-Bond Acceptors28
Rotatable Bonds27
Heavy Atoms178
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002418.68
LogP ≤ 524.10
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1028

Analyze [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

US20250214942, Example 15
CID 156196613
US20250214942, Example 48
CID 156196641
(3-((1H-pyrazolo[4,3-b]-pyridin-1-yl)methyl)bicyclo-[1.1.1]pentan-1-yl)(5-(3,5-difluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)methanone
CID 156199486
US20250214942, Example 59
CID 156199579
US20250214942, Example 88
CID 156199640
US20250214942, Example 87
CID 156199736
US20250214942, Example 165
CID 156199741
[3-(3,5-Difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(5-methylpyrazolo[4,3-b]pyridin-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone
CID 157261738
[3-(3,5-Difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(5-methylpyrazolo[3,4-c]pyridin-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone
CID 157655451
[3-(3,5-Difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(6-methylpyrazolo[4,3-b]pyridin-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone
CID 157727311
[3-(3,5-Difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-methylpyrazolo[5,4-c]pyridin-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone
CID 157919473
[3-(3,5-Difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(5-methylpyrazolo[5,4-c]pyridin-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone
CID 160468451

Frequently Asked Questions

What is the IUPAC name of [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone?
The IUPAC name of [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone (CID 158763937) is [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone.
What is the SMILES notation for [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone?
The canonical SMILES for [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone is CCCc1cn(CC23CC(C(=O)N4N=CCC4c4cc(F)cc(F)c4)(C2)C3)nn1.CCc1cn(CC23CC(C(=O)N4N=CCC4c4cc(F)cc(F)c4)(C2)C3)nn1.Cc1c2ccccc2nn1CC12CC(C(=O)N3N=CCC3c3cc(F)cc(F)c3)(C1)C2.Cc1cnc(C2CC=NN2C(=O)C23CC(Cn4ncc5ccccc54)(C2)C3)cn1.Cc1nn(CC23CC(C(=O)N4N=CCC4c4cc(F)cc(F)c4)(C2)C3)c2ccccc12.O=C(N1N=CCC1c1cc(F)cc(F)c1)C12CC(Cn3ncc4ccccc43)(C1)C2.
What is the InChIKey of [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone?
The InChIKey is IPAFKYUFQPLGAJ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C24H22F2N4O.C23H20F2N4O.C22H22N6O.C21H23F2N5O.C20H21F2N5O/c1-15-19-4-2-3-5-21(19)29(28-15)14-23-11-24(12-23,13-23)22(31)30-20(6-7-27-30)16-8-17(25)10-18(26)9-16;1-15-19-4-2-3-5-20(19)28-29(15)14-23-11-24(12-23,13-23)22(31)30-21(6-7-27-30)16-8-17(25)10-18(26)9-16;24-17-7-16(8-18(25)9-17)20-5-6-26-29(20)21(30)23-11-22(12-23,13-23)14-28-19-4-2-1-3-15(19)10-27-28;1-15-8-24-17(10-23-15)19-6-7-25-28(19)20(29)22-11-21(12-22,13-22)14-27-18-5-3-2-4-16(18)9-26-27;1-2-3-17-9-27(26-25-17)13-20-10-21(11-20,12-20)19(29)28-18(4-5-24-28)14-6-15(22)8-16(23)7-14;1-2-16-8-26(25-24-16)12-19-9-20(10-19,11-19)18(28)27-17(3-4-23-27)13-5-14(21)7-15(22)6-13/h2-5,7-10,20H,6,11-14H2,1H3;2-5,7-10,21H,6,11-14H2,1H3;1-4,6-10,20H,5,11-14H2;2-5,7-10,19H,6,11-14H2,1H3;5-9,18H,2-4,10-13H2,1H3;4-8,17H,2-3,9-12H2,1H3.
What are the key properties of [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone?
[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone has a molecular weight of 2418.68 g/mol, XLogP of 24.10, 27 rotatable bonds, 0 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for [3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-ethyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(3-methylindazol-2-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(3,5-difluorophenyl)-3,4-dihydropyrazol-2-yl]-[3-[(4-propyltriazol-1-yl)methyl]-1-bicyclo[1.1.1]pentanyl]methanone;[3-(indazol-1-ylmethyl)-1-bicyclo[1.1.1]pentanyl]-[3-(5-methylpyrazin-2-yl)-3,4-dihydropyrazol-2-yl]methanone is sourced from PubChem (CID 158763937), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).